{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T23:20:57Z","timestamp":1697844057294},"reference-count":144,"publisher":"BMJ","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Archives of Disease in Childhood"],"published-print":{"date-parts":[[1980,2,1]]},"DOI":"10.1136\/adc.55.2.89","type":"journal-article","created":{"date-parts":[[2008,12,22]],"date-time":"2008-12-22T21:33:49Z","timestamp":1229981629000},"page":"89-98","source":"Crossref","is-referenced-by-count":23,"title":["Drug level monitoring in paediatric practice."],"prefix":"10.1136","volume":"55","author":[{"given":"G W","family":"Rylance","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T A","family":"Moreland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","reference":[{"key":"ref_1","first-page":"153","article-title":"Drug availability and dosage information for children","volume":"4","author":"W, Rylance G.","year":"1979","unstructured":"Rylance G W. Drug availability and dosage information for children. J Clin Pharmacol 1979; 4: 153-8.","journal-title":"J Clin Pharmacol"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1001\/archneur.1974.00490410037002","article-title":"Anticonvulsant effect of diphenylhydantoin relative to plasma levels. A prospective three-year study in ambulant patients with generalised epileptic seizures","volume":"31","author":"Lund, L.","year":"1974","unstructured":"Lund L. Anticonvulsant effect of diphenylhydantoin relative to plasma levels. A prospective three-year study in ambulant patients with generalised epileptic seizures. Arch Neurol 1974; 31: 289-94.","journal-title":"Arch Neurol"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1136\/adc.54.6.454","article-title":"Carbamazepine dose-frequency requirement in children","volume":"54","author":"W, Rylance G.; A, Moreland T.; M, Butcher G.","year":"1979","unstructured":"Rylance G W, Moreland T A, Butcher G M. Carbamazepine dose-frequency requirement in children. Arch Dis Child 1979; 54: 454-8.","journal-title":"Arch Dis Child"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2165\/00003088-197601010-00005","article-title":"Plasma level monitoring of anticonvulsants","volume":"1","author":"J, Eadie M.","year":"1976","unstructured":"Eadie M J. Plasma level monitoring of anticonvulsants. Clin Pharmacokinet 1976; 1: 52-6.","journal-title":"Clin Pharmacokinet"},{"key":"ref_5","first-page":"295","article-title":"Carbamazepine biotransformation","volume":"11","author":"Frigerio, A.; L, Morselli P.","year":"1975","unstructured":"Frigerio A, Morselli P L. Carbamazepine biotransformation. Adv Neurol 1975; 11: 295-308.","journal-title":"Adv Neurol"},{"key":"ref_6","first-page":"\"120","article-title":"The chemistry of carbamazepine","volume":"30","author":"R, Gagneux A.","year":"1976","unstructured":"Gagneux A R. The chemistry of carbamazepine. In: Birkmayer W, ed. Epileptic seizures-behaviour-pain. Berne: Huber, 1976: 120-6. McKenzie M W, Stewart R B, Weiss C F, Cluff L E. A pharmacist based study of the epidemiology of adverse drug reactions in pediatric medicine patients. Am J Hosp Pharm 1973; 30: 898-903.","journal-title":"Am J Hosp Pharm; A pharmacist based study of the epidemiology of adverse drug reactions in pediatric medicine patients"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF00560256","article-title":"Patterns of drug prescribing for children in hospital","volume":"14","author":"A, Moreland T.; W, Rylance G.; J, Christopher L.; H, Stevenson I.","year":"1978","unstructured":"Moreland T A, Rylance G W, Christopher L J, Stevenson I H. Patterns of drug prescribing for children in hospital. Eur J Clin Pharmacol 1978; 14: 39-46.","journal-title":"Eur J Clin Pharmacol"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/bmj.1.6001.61","article-title":"Pattern and quality of recording pre-admission drug treatment in paediatric patients","volume":"i:","author":"Whyte, J.; Greenan, E.","year":"1976","unstructured":"Whyte J, Greenan E. Pattern and quality of recording pre-admission drug treatment in paediatric patients. Br Med J 1976; i: 61-3.","journal-title":"Br Med J"},{"key":"ref_9","first-page":"\"337","article-title":"Plasma kinetics of carbamazepine and its epoxide metabolite in man after single and multiple doses","volume":"8","author":"Eichelbaum, M.; Ekbom, K.; A, Bertilsson V.; A, Ringberger V.; Rane, A.","year":"1975","unstructured":"Eichelbaum M, Ekbom K, Bertilsson V A, Ringberger V A, Rane A. Plasma kinetics of carbamazepine and its epoxide metabolite in man after single and multiple doses. EurJ Clin Pharmacol 1975; 8: 337-41. van der Kleijn E, Van Rossum J M, Muskens E T J M, Rijntjes N V M. Pharmacokinetics of diazepam in dogs, mice, and humans. Acta Pharmacol Toxicol (Kbh) 1971 29: Supplement 3, 109-27.","journal-title":"EurJ Clin Pharmacol; Pharmacokinetics of diazepam in dogs, mice, and humans"},{"key":"ref_10","first-page":"99","article-title":"Pharmacokinetics and metabolism of the hypnotic nitrazepam","volume-title":"L 0, eds. The benzodiazepines","author":"Rieder, J.; Wendt, G.","year":"1973","unstructured":"Rieder J, Wendt G. Pharmacokinetics and metabolism of the hypnotic nitrazepam. In: Garattini S, Mussini E, Randall L 0, eds. The benzodiazepines. New York: Raven Press, 1973: 99-127."},{"issue":"85","key":"ref_11","first-page":"166","article-title":"Determination of plasma and cerebrospinal fluid levels of Dilantin in the human","volume":"1960","author":"M, Triedman H.; A, Fishman R.; D, Yahr M.","unstructured":"Triedman H M, Fishman R A, Yahr M D. Determination of plasma and cerebrospinal fluid levels of Dilantin in the human. Trans Amer Neurol Assoc 1960; 85: 166-70.","journal-title":"Trans Amer Neurol Assoc"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/cpt1972132196","article-title":"Plasma protein binding of diphenylhydantoin in patients with epilepsy. Agreement between the unbound fraction in plasma and the concentration in cerebrospinal fluid","volume":"13","author":"Lund, L.; Berlin, A.; M, Lunde P.K.","year":"1972","unstructured":"Lund L, Berlin A, Lunde P K M. Plasma protein binding of diphenylhydantoin in patients with epilepsy. Agreement between the unbound fraction in plasma and the concentration in cerebrospinal fluid. Clin Pharmacol Ther 1972; 13: 196-200.","journal-title":"Clin Pharmacol Ther"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1528-1157.1975.tb06063.x","article-title":"Absorption and distribution of antiepileptic drugs","volume":"16","author":"Meinardi, H.; van der Kleijn, E.; A, Meijer J.W.; van Rees, H.","year":"1975","unstructured":"Meinardi H, van der Kleijn E, Meijer J W A, van Rees H. Absorption and distribution of antiepileptic drugs. Epilepsia 1975; 16: 353-65.","journal-title":"Epilepsia"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0140-6736(70)91506-0","article-title":"Letter: Abnormal pharmacokinetics of phenytoin in a patient with uraemia","volume":"2","author":"Odar-Cederlof, I.; Lunde, P.; Sjoqvist, F.","year":"1970","unstructured":"Odar-Cederlof I, Lunde P, Sjoqvist F. Letter: Abnormal pharmacokinetics of phenytoin in a patient with uraemia. Lancet 1970; 2: 831-2.","journal-title":"Lancet"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1056\/NEJM197107292850506","article-title":"Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function","volume":"285","year":"1971","unstructured":"Reidenberg M M, Odar-Cederlof I, von Bahr C, Borga 0, Sjoqvist F. Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function. N EnglJ Med 1971; 285: 264-7.","journal-title":"N EnglJ Med"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000136286","article-title":"The alteration of plasma proteins in uraemia as reflected in their ability to bind digitoxin and diphenylhydantoin","volume":"7","author":"W, Shoeman D.; L, Azarnoff D.","year":"1972","unstructured":"Shoeman D W, Azarnoff D L. The alteration of plasma proteins in uraemia as reflected in their ability to bind digitoxin and diphenylhydantoin. Pharmacology 1972; 7: 169-77.","journal-title":"Pharmacology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/cpt1974153276","article-title":"Plasma protein binding of diphenylhydantoin. Effects of sex hormones, renal, and liver disease","volume":"15","author":"D, Hooper W.; F, Bochner; J, Eadie M.; H, Tyrer J.","year":"1974","unstructured":"Hooper W D, Bochner F, Eadie M J, Tyrer J H. Plasma protein binding of diphenylhydantoin. Effects of sex hormones, renal, and liver disease. Clin Pharmacol Ther 1974; 15: 276-82.","journal-title":"Clin Pharmacol Ther"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/archneur.1976.00500050037007","article-title":"Interlaboratory variability in determination of plasma antiepileptic drug concentrations","volume":"33","author":"E, Pippenger C.; K, Penry J.; G, White B.; D, Daly D.; R, Buddington","year":"1976","unstructured":"Pippenger C E, Penry J K, White B G, Daly D D, Buddington R. Interlaboratory variability in determination of plasma antiepileptic drug concentrations. Arch Neurol 1976; 33: 351-5.","journal-title":"Arch Neurol"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/978-3-642-85921-2_30","article-title":"Results of a phenytoin quality control scheme","volume-title":"Clinical pharmacology of anti-epileptic drugs","author":"Richens, A.","year":"1975","unstructured":"Richens A. Results of a phenytoin quality control scheme. In: Schneider H, Janz D, Gardner-Thorpe C, Meinardi H, Sherwin A I, eds. Clinical pharmacology of anti-epileptic drugs. Berlin, Springer-Verlag, 1975: 293-302."},{"key":"ref_20","first-page":"42","article-title":"The North American antiepileptic drug quality control programme","volume-title":"Antiepileptic drug monitoring","author":"E, Pippenger C.; K, Penry J.; D, Daly D.; H, Paris-Kutt","year":"1977","unstructured":"Pippenger C E, Penry J K, Daly D D, Paris-Kutt H. The North American antiepileptic drug quality control programme. In: Gardner-Thorpe C, Janz D, Meinardi H, Pippenger C E, eds. Antiepileptic drug monitoring. Tunbridge Wells: Pitman, 1977: 42-5."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1203\/00006450-197009000-00083","article-title":"Kim 0 K. Apparent saturation of diphenylhydantoin metabolism in children (abstract)","volume":"4","author":"K, Garrettson L.","year":"1970","unstructured":"Garrettson L K, Kim 0 K. Apparent saturation of diphenylhydantoin metabolism in children (abstract). Pediatr Res 1970; 4: 455.","journal-title":"Pediatr Res"},{"issue":"94","key":"ref_22","first-page":"1265","article-title":"Die Bedeutung von Kumulation","volume":"1969","author":"Remmer, H.; Hirschmann, J.; Greiner, I.","unstructured":"Remmer H, Hirschmann J, Greiner I. Die Bedeutung von Kumulation und Elimination fur die Dosierung von Phenytoin (Diphenylhydantoin). Dtsch Med Wochenschr 1969; 94: 1265-72.","journal-title":"Dtsch Med Wochenschr; Dosierung von Phenytoin (Diphenylhydantoin"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/cpt1970111121","article-title":"The rate of decline of diphenylhydantoin in human plasma","volume":"11","author":"Arnold, K.; Gerber, N.","year":"1970","unstructured":"Arnold K, Gerber N. The rate of decline of diphenylhydantoin in human plasma. Clin Pharmacol Ther 1970; 11: 121-34.","journal-title":"Clin Pharmacol Ther"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"765","DOI":"10.7326\/0003-4819-77-5-765","article-title":"Acute intoxication with 5,5-dipherylhydantoin (Dilantin) associated with impairment of biotransformation","volume":"77","author":"Gerber, N.; Lynn, R.; Oates, J.","year":"1972","unstructured":"Gerber N, Lynn R, Oates J. Acute intoxication with 5,5-dipherylhydantoin (Dilantin) associated with impairment of biotransformation. Ann Intern Med 1972; 77: 765-71.","journal-title":"Ann Intern Med"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/cpt1975174481","article-title":"Diphenylhydantoin elimination kinetics in overdosed children","volume":"17","author":"K, Garrettson L.; J, Jusko W.","year":"1975","unstructured":"Garrettson L K, Jusko W J. Diphenylhydantoin elimination kinetics in overdosed children. Clin Pharmacol Ther 1975; 17: 481-91.","journal-title":"Clin Pharmacol Ther"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0022-3476(72)80561-4","article-title":"Diphenylhydantoin: efficacy, toxicity, and dose-serum level relationship in children","volume":"81","author":"G, Borofsky L.; S, Louis; H, Kutt; M, Roginsky","year":"1972","unstructured":"Borofsky L G, Louis S, Kutt H, Roginsky M. Diphenylhydantoin: efficacy, toxicity, and dose-serum level relationship in children. JPediatr 1972; 81: 995-1002.","journal-title":"JPediatr"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000114679","article-title":"Systematic determination of the serum phenytoin level as an aid in the management of children with epilepsy","volume":"13","author":"Norell, E.; Lilienberg, G.; Gamstorp, I.","year":"1975","unstructured":"Norell E, Lilienberg G, Gamstorp I. Systematic determination of the serum phenytoin level as an aid in the management of children with epilepsy. Eur Neurol 1975; 13: 232-44.","journal-title":"Eur Neurol"},{"issue":"2","key":"ref_28","first-page":"624","article-title":"Clinical and electroencephalographic correlation with serum levels of diphenylhydantoin","volume":"1960","unstructured":"Buchthal F, Svensmark 0, Schiller P J. Clinical and electroencephalographic correlation with serum levels of diphenylhydantoin. Arch Neurol 1960; 2: 624-30.","journal-title":"Arch Neurol"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1212\/WNL.26.8.715","article-title":"Phenytoin kinetics in children","volume":"26","author":"G, Curless R.; D, Walson P.; E, Carter D.","year":"1976","unstructured":"Curless R G, Walson P D, Carter D E. Phenytoin kinetics in children. Neurology (Minneap) 1976; 26: 715-20.","journal-title":"Neurology (Minneap)"},{"key":"ref_30","first-page":"801","article-title":"Steady-state phenytoin kinetics in children determined from saliva (abstract)","volume":"54","author":"W, Rylance G.; A, Moreland T.; G, Fowles R.","year":"1979","unstructured":"Rylance G W, Moreland T A, Fowles R G. Steady-state phenytoin kinetics in children determined from saliva (abstract). In Proceedings of the Paediatric Research Society. Arch Dis Child 1979; 54: 801.","journal-title":"Proceedings of the Paediatric; Research Society. Arch Dis Child"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1528-1157.1974.tb04011.x","article-title":"One daily dose of diphenylhydantoin for patients with epilepsy","volume":"15","author":"I, Strandjord R.E.Johannessen S.","year":"1974","unstructured":"Strandjord R E. Johannessen S I. One daily dose of diphenylhydantoin for patients with epilepsy. Epilepsia 1974; 15: 317-27. 3 4Buchanan R A, Turner J L, Moyer C E, Heffelfinger J C.","journal-title":"Epilepsia"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0022-3476(73)80281-1","article-title":"Single daily dose of diphenylhydantoin in children","volume":"83","year":"1973","unstructured":"Single daily dose of diphenylhydantoin in children. J Pediatr 1973; 83: 479-83.","journal-title":"J Pediatr"},{"key":"ref_33","first-page":"185","article-title":"Clinical pharmacology and medical treatment","volume-title":"A textbook of epilepsy","author":"Richens, A.","year":"1976","unstructured":"Richens A. Clinical pharmacology and medical treatment. In: Laidlaw J, Richens A, eds. A textbook of epilepsy. Edinburgh: Churchill Livingstone, 1976: 185-247."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1001\/archneur.1968.00480060037004","article-title":"Relation of EEG and seizures to phenobarbital in serum","volume":"19","year":"1968","unstructured":"Buchthal F, Svensmark 0, Simonsen H. Relation of EEG and seizures to phenobarbital in serum. Arch Neurol 1968; 19: 567-72.","journal-title":"Arch Neurol"},{"key":"ref_35","first-page":"335","article-title":"Relation of serum concentration to control of seizures","author":"Buchthal, F.; Phenobarbital, Lennox-Buchthal M.A.","year":"1972","unstructured":"Buchthal F, Lennox-Buchthal M A. Phenobarbital. Relation of serum concentration to control of seizures. In: Woodbury D M, Penry J K, Schmidt R P, eds. Antiepileptic drugs. New York: Raven Press, 1972: 335-43."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/clinchem\/16.2.135","article-title":"Concurrent assay of phenobarbital and diphenylhydantoin in plasma by vapour phase chromatography","volume":"16","author":"C, Van Meter J.; S, Buckmaster H.; L, Shelley L.","year":"1970","unstructured":"Van Meter J C, Buckmaster H S, Shelley L L. Concurrent assay of phenobarbital and diphenylhydantoin in plasma by vapour phase chromatography. Clin Chem 1970; 16: 135-8.","journal-title":"Clin Chem"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1469-8749.1965.tb08228.x","article-title":"The clinical use of serum determinations of phenytoin and phenobarbital in children","volume":"7","author":"C, Melchior J.","year":"1965","unstructured":"9Melchior J C. The clinical use of serum determinations of phenytoin and phenobarbital in children. Dev Med Child Neurol 1965; 7: 387-91.","journal-title":"Dev Med Child Neurol"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/archpedi.1964.02090010084011","article-title":"Diphenylhydantoin and phenobarbital serum levels in children","volume":"108","author":"Svensmark 0, Buchthal F","year":"1964","unstructured":"Svensmark 0, Buchthal F. Diphenylhydantoin and phenobarbital serum levels in children. Am J Dis Child 1964; 108: 82-7.","journal-title":"Am J Dis Child"},{"key":"ref_39","first-page":"117","article-title":"Serum concentrations of diphenylhydantoin (phenytoin) and phenobarbital and their relation to therapeutic and toxic effects","volume":"74","author":"Buchthal, F, Svensmark 0","year":"1971","unstructured":"Buchthal F, Svensmark 0. Serum concentrations of diphenylhydantoin (phenytoin) and phenobarbital and their relation to therapeutic and toxic effects. Psychiatr Neurol Neurochir 1971; 74: 117-36.","journal-title":"Psychiatr Neurol Neurochir"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1528-1157.1972.tb05262.x","article-title":"Thorn 1. Successful prophylaxis of febrile convulsions with phenobarbital","volume":"13","year":"1972","unstructured":"Faer0 0, Kastrup K W, Nielsen E L, Melchior J C, Thorn 1. Successful prophylaxis of febrile convulsions with phenobarbital. Epilepsia 1972; 13: 279-85.","journal-title":"Epilepsia"},{"key":"ref_41","first-page":"559","article-title":"Failure of phenobarbitone to prevent febrile convulsions","volume":"i:","author":"Z, Heckmatt J.; B, Houston A.; J, Clow D.","year":"1976","unstructured":"3Heckmatt J Z, Houston A B, Clow D J, et al. Failure of phenobarbitone to prevent febrile convulsions. Br MedJ 1976; i: 559-61.","journal-title":"Br MedJ"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/cpt1970115674","article-title":"Disappearance of phenobarbital and diphenylhydantoin from serum of children","volume":"11","author":"K, Garrettson L.; G, Dayton P.","year":"1970","unstructured":"4Garrettson L K, Dayton P G. Disappearance of phenobarbital and diphenylhydantoin from serum of children. Clin Pharmacol Ther 1970; 11: 674-9.","journal-title":"Clin Pharmacol Ther"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF00607431","article-title":"Pharmacokinetics of phenobarbital in childhood","volume":"12","author":"Heimann, G.; Gladtke, E.","year":"1977","unstructured":"Heimann G, Gladtke E. Pharmacokinetics of phenobarbital in childhood. Eur J Clin Pharmacol 1977; 12: 305-10.","journal-title":"Eur J Clin Pharmacol"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1528-1157.1970.tb03893.x","article-title":"The relationship of the anticonvulsant properties of primidone to phenobarbital","volume":"11","author":"B, Gallagher B.; B, Smith D.; H, Mattson R.","year":"1970","unstructured":"Gallagher B B, Smith D B, Mattson R H. The relationship of the anticonvulsant properties of primidone to phenobarbital. Epilepsia 1970; 11: 293-301.","journal-title":"Epilepsia"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/03602537508993750","article-title":"Metabolism and pharmacokinetics of carbamazepine","volume":"4","author":"L, Morselli P.; A, Frigerio","year":"1975","unstructured":"Morselli P L, Frigerio A. Metabolism and pharmacokinetics of carbamazepine. Drug Metab Rev 1975; 4: 97-113.","journal-title":"Drug Metab Rev"},{"key":"ref_46","first-page":"60","article-title":"Carbamazepine (Tegretol) as an anticonvulsant-a controlled doubleblind comparison with diphenylhydantoin (Dilantin)","volume":"Supplement","author":"S, Troupin A.; R, Green J.; M, Halpern L.","year":"1975","unstructured":"Troupin A S, Green J R, Halpern L M. Carbamazepine (Tegretol) as an anticonvulsant-a controlled doubleblind comparison with diphenylhydantoin (Dilantin). Acta Neurol Scand 1975; Supplement 60,13-26.","journal-title":"Acta Neurol Scand"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1212\/WNL.26.10.936","article-title":"Further observations on carbamazepine plasma levels in epileptic patients","volume":"26","author":"Monaco, F.; Riccio, A.; Benna, P.","year":"1976","unstructured":"9Monaco F, Riccio A, Benna P, et al. Further observations on carbamazepine plasma levels in epileptic patients. Neurology (Minneap) 1976; 26: 936-43.","journal-title":"Neurology (Minneap)"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1528-1157.1976.tb03394.x","article-title":"A comparative controlled study between carbamazepine and diphenylhydantoin in psychomotor epilepsy","volume":"17","author":"Simonsen, N.; Z, Olsen P.; Kuhl, V.; Lund, M.; Wendelboe, J.","year":"1976","unstructured":"\u00b0Simonsen N, Olsen P Z, Kuhl V, Lund M, Wendelboe J. A comparative controlled study between carbamazepine and diphenylhydantoin in psychomotor epilepsy. Epilepsia 1976; 17: 169-76.","journal-title":"Epilepsia"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/cpt1976193276","article-title":"Kinetics of carbamazepine and its 10,11-epoxide metabolite in children","volume":"19","author":"Rane, A.; Hojer, B.; T, Wilson J.","year":"1976","unstructured":"Rane A, Hojer B, Wilson J T. Kinetics of carbamazepine and its 10,11-epoxide metabolite in children. Clin Pharmacol Ther 1976; 19: 276-83.","journal-title":"Clin Pharmacol Ther"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/cpt1978243316","article-title":"Time-course of interaction between carbamazepine and clonazepam in normal man","volume":"24","author":"A, Lai A.; H, Levy R.; E, Cutler R.","year":"1978","unstructured":"Lai A A, Levy R H, Cutler R E. Time-course of interaction between carbamazepine and clonazepam in normal man. Clin Pharmacol Ther 1978; 24: 316-23.","journal-title":"Clin Pharmacol Ther"},{"key":"ref_51","first-page":"104","article-title":"Anticonvulsant effect of carbamazepine. An attempt to distinguish between the potency of the parent drug and its epoxide metabolite","volume-title":"Antiepileptic drug monitoring","author":"W, Faigle J.; F, Feldmann K.; V, Baltzer","year":"1977","unstructured":"Faigle J W, Feldmann K F, Baltzer V. Anticonvulsant effect of carbamazepine. An attempt to distinguish between the potency of the parent drug and its epoxide metabolite. In: Gardner-Thorpe C, Janz D, Meinardi H, Pippenger C E, eds. Antiepileptic drug monitoring. Tunbridge Wells: Pitman, 1977; 104-8."},{"key":"ref_52","first-page":"110","article-title":"Further observations on carbamazepine and carbamazepine-10,11-epoxide kinetics in epileptic patients","volume-title":"Antiepileptic drug monitoring","author":"I, Johannessen S.; A, Baruzzi; R, Gomeni; E, Strandjord R.; L, Morselli P.","year":"1977","unstructured":"4Johannessen S I, Baruzzi A, Gomeni R, Strandjord R E, Morselli P L. Further observations on carbamazepine and carbamazepine-10,11-epoxide kinetics in epileptic patients. In: Gardner-Thorpe C, Janz D, Meinardi H, Pippenger C E, eds. Antiepileptic drug monitoring. Tunbridge Wells: Pitman, 1977: 110-23."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1469-8749.1975.tb04698.x","article-title":"The treatment of childhood epilepsy with sodium valproate","volume":"17","author":"Haigh, D.; D, Forsythe W.","year":"1975","unstructured":"Haigh D, Forsythe W D. The treatment of childhood epilepsy with sodium valproate. Dev Med Child Neurol 1975; 17: 743-8.","journal-title":"Dev Med Child Neurol"},{"key":"ref_54","first-page":"9","article-title":"Treatment of generalised epilepsies of childhood and adolescence with sodium valproate (Epilim)","volume":"19","author":"M, Jeavons P.; E, Clark J.; C, Maheshwani M.","year":"1977","unstructured":"Jeavons P M, Clark J E, Maheshwani M C. Treatment of generalised epilepsies of childhood and adolescence with sodium valproate (Epilim). Dev Med Child Neurol 1977; 19: 9-25.","journal-title":"Dev Med Child Neurol"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF00561557","article-title":"Pharmacokinetics of di-n-propylacetate in epileptic patients","volume":"8","year":"1975","unstructured":"Pharmacokinetics of di-n-propylacetate in epileptic patients. Eur J Clin Pharmacol 1975; 8: 97-105.","journal-title":"Eur J Clin Pharmacol"},{"key":"ref_56","first-page":"77","article-title":"Pharmacokinetics and efficacy of Epilim in patients receiving long-term therapy with other antiepileptic drugs","volume-title":"Clinical and pharmacological aspects of sodium valproate (Epilim) in the treatment of epilepsy","author":"Richens, A.; T, Scoular I.; Ahmad, S.; J, Jordan B.","year":"1976","unstructured":"Richens A, Scoular I T, Ahmad S, Jordan B J. Pharmacokinetics and efficacy of Epilim in patients receiving long-term therapy with other antiepileptic drugs. In: Legg N J, ed. Clinical and pharmacological aspects of sodium valproate (Epilim) in the treatment of epilepsy. Tunbridge Wells: MCS Consultants, 1976: 77-88."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"488","DOI":"10.2165\/00003495-197917060-00005","article-title":"When should plasma levels be measured?","volume":"17","author":"Richens, A.; Warrington, S.","year":"1979","unstructured":"9 Richens A, Warrington S. When should plasma levels be measured? Drugs 1979; 17: 488-500.","journal-title":"Drugs"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1528-1157.1977.tb04463.x","article-title":"Clinical pharmacological aspects of valproate sodium","volume":"18","author":"Wulff, K.; Flachs, H.; Wurtz-J0rgensen, A.; Gram, L.","year":"1977","unstructured":"Wulff K, Flachs H, Wurtz-J0rgensen A, Gram L. Clinical pharmacological aspects of valproate sodium. Epilepsia 1977; 18: 149-57.","journal-title":"Epilepsia"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1528-1157.1975.tb04743.x","article-title":"Concentration of dipropylacetate in plasma","volume":"16","author":"Loiseau, P.; Brachet, A.; Henry, P.","year":"1975","unstructured":"Loiseau P, Brachet A, Henry P. Concentration of dipropylacetate in plasma. Epilepsia 1975; 16: 609-15.","journal-title":"Epilepsia"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1528-1157.1979.tb04808.x","article-title":"Sodium valproate, serum level, and clinical effect in epilepsy: a controlled study","volume":"20","author":"Gram, L.; Flachs, H.; Wurtz-Jorgensen, A.; Parnas, J.; Andersen, B.","year":"1979","unstructured":"Gram L, Flachs H, Wurtz-Jorgensen A, Parnas J, Andersen B. Sodium valproate, serum level, and clinical effect in epilepsy: a controlled study. Epilepsia 1979; 20: 303-12.","journal-title":"Epilepsia"},{"key":"ref_61","first-page":"1","article-title":"The significance ofmeasuring blood levels of benzodiazepines","volume-title":"effects of drugs in relation to their plasma concentrations","volume":"21","author":"Garattini, S.; Marcucci, F.; L, Morselli P.; Mussini, E.","year":"1973","unstructured":"Garattini S, Marcucci F, Morselli P L, Mussini E. The significance ofmeasuring blood levels of benzodiazepines. In: Davies D S, Prichard B N C, eds. Biological effects of drugs in relation to their plasma concentrations. London: Macmillan, 1973: 21 1-25."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1528-1157.1975.tb06058.x","article-title":"Plasma levels of diazepam after parenteral and rectal administration in children","volume":"16","author":"Agurell, S.; Berlin, A.; Ferngren, H.; Hellstrom, B.","year":"1975","unstructured":"Agurell S, Berlin A, Ferngren H, Hellstrom B. Plasma levels of diazepam after parenteral and rectal administration in children. Epilepsia 1975; 16: 277-83.","journal-title":"Epilepsia"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1651-2227.1977.tb07947.x","article-title":"Plasma-diazepam in infants after rectal administration in solution and by suppository","volume":"66","author":"U, Knudsen F.","year":"1977","unstructured":"Knudsen F U. Plasma-diazepam in infants after rectal administration in solution and by suppository. Acta PaediatrScand 1977; 66: 563-7.","journal-title":"Acta PaediatrScand"},{"key":"ref_64","first-page":"129","article-title":"Kinetics of 14C-diazepam and its metabolites in various areas of the cat brain","volume-title":"L 0, eds. The benzodiazepines","author":"L, Morselli P.; B, Cassano G.; F, Placidi G.; B, Muscettola G.; M, Rizzo","year":"1973","unstructured":"Morselli P L, Cassano G B, Placidi G F, Muscettola G B, Rizzo M. Kinetics of 14C-diazepam and its metabolites in various areas of the cat brain. In: Garattini S, Mussini E, Randall L 0, eds. The benzodiazepines. New York: Raven Press, 1973: 129-43."},{"key":"ref_65","first-page":"443","article-title":"Ethosuximide: relation ofplasma level to clinical control","author":"L, Sherwin A.; P, Robb J.","year":"1972","unstructured":"Sherwin A L, Robb J P. Ethosuximide: relation ofplasma level to clinical control. In: Woodbury D M, Penry J K, Schmidt R P, eds. Antiepileptic drugs. New York: Raven Press, 1972: 443-8."},{"key":"ref_66","first-page":"431","article-title":"Ethosuximide: relation ofplasma level to clinical control","author":"K, Penry J.; J, Porter R.; E, Dreifuss F.","year":"1972","unstructured":"Penry J K, Porter R J, Dreifuss F E. Ethosuximide: relation ofplasma level to clinical control. In: Woodbury D M, Penry J K, Schmidt R P, eds. Antiepileptic drugs. New York: Raven Press, 1972: 431-41."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1001\/archneur.1973.00490210058007","article-title":"Improved control of epilepsy by monitoring plasma ethosuximide","volume":"28","author":"L, Sherwin A.; P, Robb J.; M, Lechter","year":"1973","unstructured":"Sherwin A L, Robb J P, Lechter M. Improved control of epilepsy by monitoring plasma ethosuximide. Arch Neurol 1973; 28: 178-81.","journal-title":"Arch Neurol"},{"key":"ref_68","first-page":"141","article-title":"The use of concentrations of digitalis for quantitative therapeutic decisions","volume":"6","author":"B, Sheiner L.","year":"1974","unstructured":"Sheiner L B. The use of concentrations of digitalis for quantitative therapeutic decisions. Cardiovasc Clin 1974; 6: 141-51.","journal-title":"Cardiovasc Clin"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/cpt1974161part2284","article-title":"Influence of serum digoxin concentration measurements on frequency of digitoxicity","volume":"16","author":"Koch-Weser, J.; W, Duhme D.; J, Greenblatt D.","year":"1974","unstructured":"Koch-Weser J, Duhme D W, Greenblatt D J. Influence of serum digoxin concentration measurements on frequency of digitoxicity. Clin Pharmacol Ther 1974; 16: 284-7.","journal-title":"Clin Pharmacol Ther"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/0002-9343(75)90118-7","article-title":"Digitalis toxicity: epidemiology and clinical use of serum concentration measurements","volume":"58","author":"W, Smith T.","year":"1975","unstructured":"Smith T W. Digitalis toxicity: epidemiology and clinical use of serum concentration measurements. Am J Med 1975; 58: 470-6.","journal-title":"Am J Med"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1056\/NEJM197604152941603","article-title":"The serum digitalis concentration-does it diagnose digitalis toxicity?","volume":"294","author":"A, Ingelfinger J.; P, Goldman","year":"1976","unstructured":"Ingelfinger J A, Goldman P. The serum digitalis concentration-does it diagnose digitalis toxicity? N Engl J Med 1976; 294: 867-99.","journal-title":"N Engl J Med"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0033-0620(72)90009-6","article-title":"Assays of digitalis in the blood","volume":"14","author":"P, Butler V.","year":"1972","unstructured":"Butler V P. Assays of digitalis in the blood. Prog Cardiovasc Dis 1972; 14: 571-600.","journal-title":"Prog Cardiovasc Dis"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1136\/adc.48.1.55","article-title":"Plasma digoxin levels in infants","volume":"48","author":"O'Malley, K.; N, Coleman E.; B, Doig W.; H, Stevenson I.","year":"1973","unstructured":"O'Malley K, Coleman E N, Doig W B, Stevenson I H. Plasma digoxin levels in infants. Arch Dis Child 1973; 48: 55-7.","journal-title":"Arch Dis Child"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1542\/peds.52.4.561","article-title":"Serum digoxin studies in infants and children","volume":"52","author":"J, Hayes C.; Butler V P, Jr, Gersony W.M.","year":"1973","unstructured":"6Hayes C J, Butler V P, Jr, Gersony W M. Serum digoxin studies in infants and children. Pediatrics 1973; 52: 561-8.","journal-title":"Pediatrics"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/01.CIR.49.6.1047","article-title":"and urinary digoxin levels during cardiopulmonary bypass in children","volume":"49","author":"Serum, atrial","year":"1974","unstructured":"Serum, atrial, and urinary digoxin levels during cardiopulmonary bypass in children. Circulation 1974; 49: 1047-52.","journal-title":"Circulation"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1161\/01.CIR.46.4.816","article-title":"Effect of digoxin on systolic time intervals of neonates and infants","volume":"46","author":"M, Levy A.; M, Leaman D.; S, Hanson J.","year":"1972","unstructured":"Levy A M, Leaman D M, Hanson J S. Effect of digoxin on systolic time intervals of neonates and infants. Circulation 1972; 46: 816-23.","journal-title":"Circulation"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0022-3476(79)80041-4","article-title":"Dosage of digoxin in premature infants","volume":"94","author":"W, Pinsky W.; R, Jacobsen J.; C, Gillette P.; J, Adams; L, Monroe; G, McNamara D.","year":"1979","unstructured":"Pinsky W W, Jacobsen J R, Gillette P C, Adams J, Monroe L, McNamara D G. Dosage of digoxin in premature infants. JPediatr 1979; 94: 639-42.","journal-title":"JPediatr"},{"issue":"30","key":"ref_78","first-page":"332","article-title":"Letter: Digoxin dosage in newborn animals and infants","volume":"1962","author":"Marini, A.; Sereni, F.; Bottino, D.","unstructured":"Marini A, Sereni F, Bottino D. Letter: Digoxin dosage in newborn animals and infants. Pediatrics 1962; 30: 332-3.","journal-title":"Pediatrics"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0022-3476(74)80732-8","article-title":"Evaluation of oral bronchodilator therapy in asthmatic children","volume":"84","author":"Weinberger, M.; A, Bronsky E.","year":"1974","unstructured":"Weinberger M, Bronsky E A. Evaluation of oral bronchodilator therapy in asthmatic children. J Pediatr 1974; 84: 421-7.","journal-title":"J Pediatr"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/cpt1975175585","article-title":"Interaction of ephedrine and theophylline","volume":"17","author":"Weinberger, M.; A, Bronsky E.","year":"1975","unstructured":"Weinberger M, Bronsky E A. Interaction of ephedrine and theophylline. Clin Pharmacol Ther 1975; 17: 585-92.","journal-title":"Clin Pharmacol Ther"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0140-6736(77)92601-0","article-title":"Comparison of cromoglycate (Cromolyn) and theophylline in controlling symptoms of chronic asthma","volume":"1","author":"Hambleton, G.; Weinberger, M.; Taylor, J.","year":"1977","unstructured":"Hambleton G, Weinberger M, Taylor J, et al. Comparison of cromoglycate (Cromolyn) and theophylline in controlling symptoms of chronic asthma. Lancet 1977; 1: 381-5.","journal-title":"Lancet"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0022-3476(77)81051-2","article-title":"Dose-dependent kinetics of theophylline disposition in asthmatic children","volume":"91","author":"Weinberger, M.; Ginchansky, E.","year":"1977","unstructured":"Weinberger M, Ginchansky E. Dose-dependent kinetics of theophylline disposition in asthmatic children. J Pediatr 1977; 91: 820-4.","journal-title":"J Pediatr"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0022-3476(77)80527-1","article-title":"Relationship of theophylline clearance to oral dosage in children with chronic asthma","volume":"91","author":"Ginchansky, E.; Weinberger, M.","year":"1977","unstructured":"Ginchansky E, Weinberger M. Relationship of theophylline clearance to oral dosage in children with chronic asthma. JPediatr 1977; 91: 655-60.","journal-title":"JPediatr"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"784","DOI":"10.7326\/0003-4819-82-6-784","article-title":"Theophylline-induced seizures in adults","volume":"82","author":"W, Zwillich C.; Sutton F D, Jr, Neff T.A.","year":"1975","unstructured":"Zwillich C W, Sutton F D, Jr, Neff T A, et al. Theophylline-induced seizures in adults. Ann Intern Med 1975; 82: 784-7.","journal-title":"Ann Intern Med"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0022-3476(75)80374-X","article-title":"Pharmacokinetic analysis of the effect oftheophylline on pulmonary function in asthmatic children","volume":"86","author":"Levy, G.; Koysooko, R.","year":"1975","unstructured":"Levy G, Koysooko R. Pharmacokinetic analysis of the effect oftheophylline on pulmonary function in asthmatic children. JPediatr 1975; 86: 789-93.","journal-title":"JPediatr"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1542\/peds.58.4.542","article-title":"Pharmacokinetics of theophylline in children with asthma","volume":"58","author":"J, Ellis R.; R, Koysooko; G, Levy","year":"1976","unstructured":"Ellis R J, Koysooko R, Levy G. Pharmacokinetics of theophylline in children with asthma. Pediatrics 1976; 58: 542-7.","journal-title":"Pediatrics"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S0022-3476(76)81136-5","article-title":"Pharmacokinetic analysis of the disposition of intravenous theophylline in young children","volume":"88","author":"M, Loughnan P.; S, Sitar D.; I, Ogilvie R.; A, Eisen; Z, Fox; H, Neims A.","year":"1976","unstructured":"Loughnan P M, Sitar D S, Ogilvie R I, Eisen A, Fox Z, Neims A H. Pharmacokinetic analysis of the disposition of intravenous theophylline in young children. J Pediatr 1976; 88: 874-9.","journal-title":"J Pediatr"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1136\/adc.53.12.943","article-title":"Serum theophylline levels in asthmatic children after oral administration of two slow-release theophylline preparations","volume":"53","author":"McKenzie, S.; Baillie, E.","year":"1978","unstructured":"McKenzie S, Baillie E. Serum theophylline levels in asthmatic children after oral administration of two slow-release theophylline preparations. Arch Dis Child 1978; 53: 943-6.","journal-title":"Arch Dis Child"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1542\/peds.55.5.589","article-title":"Prevention of apnea and bradycardia in low-birthweight infants","volume":"55","author":"C, Shannon D.; F, Gotay; M, Stein I.; C, Rogers M.; D, Todres I.; B, Moylan F.M.","year":"1975","unstructured":"Shannon D C, Gotay F, Stein I M, Rogers M C, Todres I D, Moylan F M B. Prevention of apnea and bradycardia in low-birthweight infants. Pediatrics 1975; 55: 589-94.","journal-title":"Pediatrics"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/adc.54.3.190","article-title":"Dosage schedule for intravenous aminophylline in apnoea of prematurity, based on pharmacokinetic studies","volume":"54","author":"K, Jones R.A.; E, Baillie","year":"1979","unstructured":"Jones R A K, Baillie E. Dosage schedule for intravenous aminophylline in apnoea of prematurity, based on pharmacokinetic studies. Arch Dis Child 1979; 54: 190-3.","journal-title":"Arch Dis Child"},{"key":"ref_91","first-page":"35","article-title":"Juvenile rheumatoid arthritis","volume-title":"5 Ansell B M. Relationship of dosage and type of salicylate therapy to plasma levels in patients with rheumatoid arthritis","volume":"9","author":"J, Jr, Brewer E.","year":"1970","unstructured":"; 53 322-5. 9 4 Brewer E J, Jr. Juvenile rheumatoid arthritis. Philadelphia: Saunders, 1970. 9 5 Ansell B M. Relationship of dosage and type of salicylate therapy to plasma levels in patients with rheumatoid arthritis. In: Dixon A St J, Martin B K, Smith M J H, Wood P H N, eds. Salicylates. London: Churchill, 1963: 35-7."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1651-2227.1979.tb05031.x","article-title":"Dosage of salicylates for children with juvenile rheumatoid arthritis","volume":"68","author":"Makale, A.-L.; Yrjana, T.; Mattila, M.","year":"1979","unstructured":"6 Makale A-L, Yrjana T, Mattila M. Dosage of salicylates for children with juvenile rheumatoid arthritis. Acta Paediatr Scand 1979; 68: 423-30.","journal-title":"Acta Paediatr Scand"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0022-3476(70)80001-4","article-title":"Management of juvenile rheumatoid arthritis","volume":"77","author":"Y, Calabro J.","year":"1970","unstructured":"Calabro J Y. Management of juvenile rheumatoid arthritis. JPediatr 1970; 77: 355-65.","journal-title":"JPediatr"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3109\/15563656808990591","article-title":"The study of salicylate pharmacokinetics in intoxicated infants and children","volume":"1","author":"Levy, G.","year":"1968","unstructured":"Levy G. The study of salicylate pharmacokinetics in intoxicated infants and children. Clin Toxicol 1968; 1: 409-24.","journal-title":"Clin Toxicol"},{"issue":"481-8","key":"ref_95","first-page":"\"100Darrell\" # \"535","article-title":"Dosage of gentamicin for Pseudomonas infections","volume":"248","author":"Med, N.EnglJ","year":"1953","unstructured":"N EnglJ Med 1953; 248: 481-8. 100Darrell J H, Waterworth P M. Dosage of gentamicin for Pseudomonas infections. Br MedJ 1967; ii: 535-7.","journal-title":"Br MedJ"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/infdis\/124.Supplement_1.S185","article-title":"Pseudomonas bacteremia: pharmacologic and other bases for failure of treatment with gentamicin","volume":"124","author":"G, Jackson G.; S, Riff L.","year":"1971","unstructured":"Jackson G G, Riff L S. Pseudomonas bacteremia: pharmacologic and other bases for failure of treatment with gentamicin. JInfect Dis 1971; 124: S185-91.","journal-title":"JInfect Dis"},{"key":"ref_97","first-page":"477","article-title":"Experience in monitoring gentamicin therapy during treatment of serious Gramnegative sepsis","volume":"i:","author":"Noone, P.; C, Parson T.M.; R, Pattison J.; B, Slack R.C.; Garfield-Davis, D.; Hughes, K.","year":"1974","unstructured":"Noone P, Parson T M C, Pattison J R, Slack R C B, Garfield-Davis D, Hughes K. Experience in monitoring gentamicin therapy during treatment of serious Gramnegative sepsis. Br MedJ 1974; i: 477-81.","journal-title":"Br MedJ"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/infdis\/124.Supplement_1.S130","article-title":"Ototoxicity of gentamicin in man: a survey and controlled analysis of clinical experience in the United States","volume":"124","author":"G, Jackson G.; G, Arcieri","year":"1971","unstructured":"Jackson G G, Arcieri G. Ototoxicity of gentamicin in man: a survey and controlled analysis of clinical experience in the United States. J Infect Dis 1971; 124: Supplement, S130-7.","journal-title":"J Infect Dis"},{"key":"ref_99","first-page":"58","article-title":"Gentamicin blood levels: a guide to nephrotoxicity. Antimicrob Agents","volume":"8","author":"G, Dahlgren J.; T, Anderson E.; L, Hewitt W.","year":"1975","unstructured":"Dahlgren J G, Anderson E T, Hewitt W L. Gentamicin blood levels: a guide to nephrotoxicity. Antimicrob Agents Chemother 1975; 8: 58-62. 105Goodman E L, Van Gelder J, Holmes R K, Hull A R, Sanford J P. Gentamicin serum levels, dose response, and nephrotoxicity (abstract 21). In the Proceedings of the Fourteenth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, September 1974.","journal-title":"Chemother; the Proceedings of the Fourteenth Interscience Conference on Antimicrobial Agents and Chemotherapy; Gentamicin serum levels, dose response, and nephrotoxicity (abstract 21"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0022-3476(75)80316-7","article-title":"Age-dependent dose response to gentamicin","volume":"87","author":"Echeverria, P.; R, Siber G.; W, Paisley J.; L, Smith A.; H, Smith D.; Jaffe, N.","year":"1975","unstructured":"Echeverria P, Siber G R, Paisley J W, Smith A L, Smith D H, Jaffe N. Age-dependent dose response to gentamicin. JPediatr 1975; 87: 805-8.","journal-title":"JPediatr"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/infdis\/132.6.637","article-title":"Pharmacokinetics of gentamicin in children and adults","volume":"132","author":"R, Siber G.; P, Echeverria; L, Smith A.; W, Paisley J.; H, Smith D.","year":"1975","unstructured":"Siber G R, Echeverria P, Smith A L, Paisley J W, Smith D H. Pharmacokinetics of gentamicin in children and adults. JInfect Dis 1975; 132: 637-51.","journal-title":"JInfect Dis"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1136\/adc.51.5.369","article-title":"Gentamicin dosage in children","volume":"51","author":"Taylor, M.; Keane, C.","year":"1976","unstructured":"Taylor M, Keane C. Gentamicin dosage in children. Arch Dis Child 1976; 51: 369-72.","journal-title":"Arch Dis Child"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/cpt1977213362","article-title":"Kinetic model for gentamicin dosing with the use of individual patient parameters","volume":"21","author":"J, Sawchuck R.; E, Zaske D.; J, Cipolle R.; A, Wargin W.; G, Strate R.","year":"1977","unstructured":"Sawchuck R J, Zaske D E, Cipolle R J, Wargin W A, Strate R G. Kinetic model for gentamicin dosing with the use of individual patient parameters. Clin Pharmacol Ther 1977; 21: 362-9.","journal-title":"Clin Pharmacol Ther"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/jama.1977.03280040047019","article-title":"Tissue persistence of gentamicin in man","volume":"238","author":"J, Schentag J.; J, Jusko W.; E, Plaut M.; J, Cumbo T.; W, Vance J.; E, Abrutyn","year":"1977","unstructured":"Schentag J J, Jusko W J, Plaut M E, Cumbo T J, Vance J W, Abrutyn E. Tissue persistence of gentamicin in man. JAMA 1977; 238: 327-9.","journal-title":"JAMA"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0022-3476(78)80626-X","article-title":"Use of gentamicin serum levels to individualize therapy in children","volume":"93","author":"l Evans W E; S, Feldman; F, Barker L.; M, Ossi; S, Chaudhary","year":"1978","unstructured":"l Evans W E, Feldman S, Barker L F, Ossi M, Chaudhary S. Use of gentamicin serum levels to individualize therapy in children. JPediatr 1978; 93: 133-7.","journal-title":"JPediatr"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/infdis\/134.Supplement_1.S20","article-title":"Laboratory findings on tobramycin and their relation to clinical response","volume":"134","author":"A, McAllister T.; C, Tait S.","year":"1976","unstructured":"McAllister T A, Tait S C. Laboratory findings on tobramycin and their relation to clinical response. J Infect Dis 1976; 134: S20-7.","journal-title":"J Infect Dis"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1177\/003693307602100208","article-title":"Clinical bacteriology of tobramycin","volume":"21","author":"A, McAllister T.","year":"1976","unstructured":"McAllister T A. Clinical bacteriology of tobramycin. Scott Med J 1976; 21: 64-6.","journal-title":"Scott Med J"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1177\/003693307602100215","article-title":"Side-effects-international results","volume":"21","author":"Tobramycin, Speirs C.F.","year":"1976","unstructured":"Speirs C F. Tobramycin. Side-effects-international results. Scott MedJ 1976; 21: 78.","journal-title":"Scott MedJ"},{"key":"ref_109","first-page":"129","article-title":"Tobramycin sulfate: a summary of worldwide experience from clinical trials","volume":"134","author":"L, Bendush C.; R, Weber","year":"1976","unstructured":"Bendush C L, Weber R. Tobramycin sulfate: a summary of worldwide experience from clinical trials. J Infect Dis 1976; 134: S129-34.","journal-title":"J Infect Dis"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1177\/003693307602100209","article-title":"Tobramycin in paediatric use","volume":"21","author":"M, Raine P.A.; G, Young D.","year":"1976","unstructured":"Raine P A M, Young D G. Tobramycin in paediatric use. Scott Med J 1976; 21: 66-7.","journal-title":"Scott Med J"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0022-3476(78)80013-4","article-title":"The necessity for monitoring chloramphenicol levels when treating neonatal meningitis","volume":"92","author":"B, Black S.; P, Levine; R, Shinefield H.","year":"1978","unstructured":"Black S B, Levine P, Shinefield H R. The necessity for monitoring chloramphenicol levels when treating neonatal meningitis. JPediatr 1978; 92: 235-6.","journal-title":"JPediatr"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF00477548","article-title":"Studies on the concentrations of chloramphenicol in the serum and cerebrospinal fluid of neonates, infants, and small children","volume":"124","author":"Windorfer, Jr, A.; Pringsheim, W.","year":"1977","unstructured":"Windorfer A, Jr, Pringsheim W. Studies on the concentrations of chloramphenicol in the serum and cerebrospinal fluid of neonates, infants, and small children. Eur JPediatr 1977; 124: 129-38.","journal-title":"Eur JPediatr"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/adc.54.1.76","article-title":"Chloramphenicol and phenobarbitone-a drug interaction","volume":"54","author":"A, Bloxham R.; M, Durbin G.; T, Johnson; H, Winterborn M.","year":"1979","unstructured":"Bloxham R A, Durbin G M, Johnson T, Winterborn M H. Chloramphenicol and phenobarbitone-a drug interaction. Arch Dis Child 1979; 54: 76-7.","journal-title":"Arch Dis Child"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2165\/00003495-197918010-00006","article-title":"Bacterial meningitis: which regimen?","volume":"18","author":"D, Overturf G.; F, Wehrle P.","year":"1979","unstructured":"Overturf G D, Wehrle P F. Bacterial meningitis: which regimen? Drugs 1979; 18: 65-73.","journal-title":"Drugs"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/cpt1978245563","article-title":"Drug concentration in saliva","volume":"24","author":"C, Mucklow J.; R, Bending M.; C, Kahn G.; T, Dollery C.","year":"1978","unstructured":"Mucklow J C, Bending M R, Kahn G C, Dollery C T. Drug concentration in saliva. Clin Pharmacol Ther 1978; 24: 563-70.","journal-title":"Clin Pharmacol Ther"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/cpt19741661052","article-title":"Pharmacokinetics of tolbutamide: prediction by concentration in saliva","volume":"16","author":"B, Matin S.; H, Wan S.; H, Karim J.","year":"1974","unstructured":"Matin S B, Wan S H, Karim J H. Pharmacokinetics of tolbutamide: prediction by concentration in saliva. Clin Pharmacol Ther 1974; 16: 1052-8.","journal-title":"Clin Pharmacol Ther"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/clinchem\/22.6.868","article-title":"Pharmacokinetic interpretation of data gathered during therapeutic drug monitoring","volume":"22","author":"H, Dvorchik B.; S, Vesell E.","year":"1976","unstructured":"Dvorchik B H, Vesell E S. Pharmacokinetic interpretation of data gathered during therapeutic drug monitoring. Clin Chem 1976; 22: 868-78.","journal-title":"Clin Chem"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2125.1978.tb01604.x","article-title":"Letter: A method for obtaining saliva samples from infants and children","volume":"5","author":"G, Bacon C.; C, Mucklow J.; A, Saunders; D, Rawlins M.; B, Webb J.K.","year":"1978","unstructured":"Bacon C G, Mucklow J C, Saunders A, Rawlins M D, Webb J K B. Letter: A method for obtaining saliva samples from infants and children. Br J Clin Pharmacol 1978; 5: 89-90.","journal-title":"Br J Clin Pharmacol"},{"issue":"12 6","key":"ref_119","first-page":"157","article-title":"Letter: Saliva carbamazepine levels in children","volume":"1481","author":"W, Rylance G.; M, Butcher G.; A, Moreland T.","year":"1977","unstructured":"Rylance G W, Butcher G M, Moreland T A. Letter: Saliva carbamazepine levels in children. Br Med J 1977; ii: 1481. 12 6 Horning M G, Brown L, Mowlin J, Lertratanangkoon K, Kellaway P, Zion T E. Use of saliva in therapeutic drug monitoring. Clin Chem 1977; 23:157-64.","journal-title":"Br Med J; Use of saliva in therapeutic drug monitoring"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1528-1157.1975.tb04758.x","article-title":"and primidone in saliva, plasma, and cerebrospinal fluid","volume":"16","author":"Schmidt, D.; Diphenylhydantoin, Kupferberg H.J.; phenobarbital","year":"1975","unstructured":"Schmidt D, Kupferberg H J. Diphenylhydantoin, phenobarbital, and primidone in saliva, plasma, and cerebrospinal fluid. Epilepsia 1975; 16: 735-41.","journal-title":"Epilepsia"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archneur.1974.00490370083014","article-title":"Diphenylhydantoin concentrations in saliva","volume":"31","author":"Bochner, F.; D, Hooper W.; M, Sutherland J.; J, Eadie M.; H, Tyrer J.","year":"1974","unstructured":"Bochner F, Hooper W D, Sutherland J M, Eadie M J, Tyrer J H. Diphenylhydantoin concentrations in saliva. Arch Neurol 1974; 31: 57-9. 12 9 Cook C E, Amerson E, Poole W K, Lesser P, O'Tuama L.","journal-title":"Arch Neurol"},{"key":"ref_122","first-page":"742","article-title":"Phenytoin and phenobarbital concentrations in saliva and plasma measured by radioimmunoassay","volume":"18","year":"1976","unstructured":"Phenytoin and phenobarbital concentrations in saliva and plasma measured by radioimmunoassay. Clin Pharmacol Ther 1976; 18: 742-7.","journal-title":"Clin Pharmacol Ther"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2125.1977.tb00692.x","article-title":"Phenytoin concentrations in mixed, parotid, and submandibular saliva and serum measured by radioimmunoassay","volume":"4","author":"W, Paxton J.; B, Whiting; W, Stephen K.","year":"1977","unstructured":"Paxton J W, Whiting B, Stephen K W. Phenytoin concentrations in mixed, parotid, and submandibular saliva and serum measured by radioimmunoassay. Br J Clin Pharmacol 1977; 4: 185-91.","journal-title":"Br J Clin Pharmacol"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0009-8981(77)90473-9","article-title":"Relationship between carbamazepine concentrations in plasma and saliva as determined by liquid chromatography","volume":"79","author":"M, Westenberg H.G.; de Zeeuw R A; van der Kleijn E; T, Oei T.","year":"1977","unstructured":"Westenberg H G M, de Zeeuw R A, van der Kleijn E, Oei T T. Relationship between carbamazepine concentrations in plasma and saliva as determined by liquid chromatography. Clin Chim Acta 1977; 79: 155-61.","journal-title":"Clin Chim Acta"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1212\/WNL.27.5.409","article-title":"Salivary levels of anticonvulsants: a practical approach to drug monitoring","volume":"27","author":"J, McAuliffe J.; L, Sherwin A.; E, Leppik I.; A, Fayle S.; E, Pippenger C.","year":"1977","unstructured":"McAuliffe J J, Sherwin A L, Leppik I E, Fayle S A, Pippenger C E. Salivary levels of anticonvulsants: a practical approach to drug monitoring. Neurology 1977; 27: 409-13.","journal-title":"Neurology"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/cpt1975173310","article-title":"Relationship between digoxin concentrations in serum and saliva","volume":"17","author":"H, Huffman D.","year":"1975","unstructured":"Huffman D H. Relationship between digoxin concentrations in serum and saliva. Clin Pharmacol Ther 1975; 17: 310-2.","journal-title":"Clin Pharmacol Ther"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1365-2125.1976.tb04896.x","article-title":"Salivary digoxin concentrations","volume":"3","author":"Joubert P H, Muller F 0, Aucamp B N","year":"1976","unstructured":"4 Joubert P H, Muller F 0, Aucamp B N. Salivary digoxin concentrations. Br J Clin Pharmacol 1976; 3: 673-4.","journal-title":"Br J Clin Pharmacol"},{"key":"ref_128","first-page":"189","article-title":"Digoxin concentrations in serum and saliva","volume":"10","author":"J, Jusko W.; L, Gerbracht; H, Golden L.; R, Koup J.","year":"1975","unstructured":"Jusko W J, Gerbracht L, Golden L H, Koup J R. Digoxin concentrations in serum and saliva. Res Commun Chem Path Pharmacol 1975; 10: 189-92.","journal-title":"Res Commun Chem Path Pharmacol"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1365-2125.1976.tb00357.x","article-title":"Digoxin concentrations in serum and saliva: relationship to ECG changes and dosage in healthy volunteers","volume":"3","author":"Joubert P H, Aucamp B N, Muller F 0","year":"1976","unstructured":"Joubert P H, Aucamp B N, Muller F 0. Digoxin concentrations in serum and saliva: relationship to ECG changes and dosage in healthy volunteers. Br J Clin Pharmacol 1976; 3: 1053-6.","journal-title":"Br J Clin Pharmacol"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2165\/00003088-197803010-00003","article-title":"Therapeutic drug monitoring in saliva","volume":"3","author":"Danhof, M.; D, Breimer D.","year":"1978","unstructured":"Danhof M, Breimer D D. Therapeutic drug monitoring in saliva. Clin Pharmacokinet 1978; 3: 39-57.","journal-title":"Clin Pharmacokinet"},{"key":"ref_131","first-page":"1216","article-title":"Kwaliteitsbeheersing van aminofylline zetpillen","volume":"111","author":"J, De Blaey C.; G, De Boer A.","year":"1976","unstructured":"De Blaey C J, De Boer A G. Kwaliteitsbeheersing van aminofylline zetpillen. Pharmaceut Weekblad 1976; 111: 1216-21.","journal-title":"Pharmaceut Weekblad"},{"key":"ref_132","first-page":"1297","article-title":"Preliminary report on the saliva\/plasma ratio of theophylline after administration of theophylline derivatives in suppositories","volume":"110","author":"J, Knop H.; R, Kalafusz; F, Knols A.J.; van der Kleijn E","year":"1975","unstructured":"Knop H J, Kalafusz R, Knols A J F, van der Kleijn E. Preliminary report on the saliva\/plasma ratio of theophylline after administration of theophylline derivatives in suppositories. Pharmaceut Weekblad 1975; 110: 1297-9.","journal-title":"Pharmaceut Weekblad"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1365-2125.1977.tb00445.x","article-title":"Letter: Saliva and plasma concentrations of diazepam after single oral dose","volume":"4","author":"G, Giles H.; H, Zilm D.; C, Frecker R.; M, MacLeod S.; M, Sellers E.","year":"1977","unstructured":"Giles H G, Zilm D H, Frecker R C, MacLeod S M, Sellers E M. Letter: Saliva and plasma concentrations of diazepam after single oral dose. Br J Clin Pharmacol 1977; 4: 711-2.","journal-title":"Br J Clin Pharmacol"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0140-6736(76)90716-9","article-title":"Letter: Salivary concentrations of antiepileptic drugs","volume":"2","author":"Schmidt, D.","year":"1976","unstructured":"Schmidt D. Letter: Salivary concentrations of antiepileptic drugs. Lancet 1976; 2: 639.","journal-title":"Lancet"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/0006-2952(66)90163-8","article-title":"Metabolic studies of allopurinol, an inhibitor of xanthine oxidase","volume":"15","author":"B, Elion G.; A, Kovensky; H, Hitchings G.; E, Metz; W, Rundles R.","year":"1966","unstructured":"Elion G B, Kovensky A, Hitchings G H, Metz E, Rundles R W. Metabolic studies of allopurinol, an inhibitor of xanthine oxidase. Biochem Pharmacol 1966; 15: 863-80.","journal-title":"Biochem Pharmacol"},{"issue":"135","key":"ref_136","first-page":"59","article-title":"The constellation of depression: its treatment with nortriptyline. II. Clinical evaluation of nortriptyline","volume":"1962","author":"F, Bennett I.","unstructured":"Bennett I F. The constellation of depression: its treatment with nortriptyline. II. Clinical evaluation of nortriptyline. J Nerv Ment Dis 1962; 135: 59-68.","journal-title":"J Nerv Ment Dis"},{"key":"ref_137","first-page":"1","article-title":"Absorption, excretion, and metabolic fate of chloral hydrate and trichloroethanol","volume":"95","year":"1954","unstructured":"Marshall E K, Jr, Owens A H, Jr. Absorption, excretion, and metabolic fate of chloral hydrate and trichloroethanol. Johns Hopkins MedJ 1954; 95: 1-18.","journal-title":"Johns Hopkins MedJ"},{"key":"ref_138","first-page":"590","article-title":"Pharmacology of the metabolites of chlordiazepoxide and diazepam Curr Ther","volume":"7","author":"Randall L 0, Scheckel C C, Banziger R F","year":"1965","unstructured":"Randall L 0, Scheckel C C, Banziger R F. Pharmacology of the metabolites of chlordiazepoxide and diazepam Curr Ther Res 1965; 7: 590-606.","journal-title":"Res"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF00441447","article-title":"PsycLopharmacology of imipramine and desimipramine: a comparative study of their effects in normal males","volume":"5","author":"A, Di Mascio; G, Heninger; L, Klerman G.","year":"1964","unstructured":"6 Di Mascio A, Heninger G, Klerman G L. PsycLopharmacology of imipramine and desimipramine: a comparative study of their effects in normal males. Psychopharmacologia 1964; 5: 361-71.","journal-title":"Psychopharmacologia"},{"issue":"59","key":"ref_140","first-page":"1907","article-title":"Luminal bei Epilepsie","volume":"1912","author":"Hauptmann, A.","unstructured":"Hauptmann A. Luminal bei Epilepsie. Munch Med Wochenschr 1912; 59: 1907-9.","journal-title":"Munch Med Wochenschr"},{"key":"ref_141","first-page":"603","article-title":"The conversion of cortisone to cortisol and prednisone to","volume-title":"prednisolone in man. Proc R Soc Med 1966","volume":"59","author":"S, Jenkins J.; A, Sampson P.","unstructured":"Jenkins J S, Sampson P A. The conversion of cortisone to cortisol and prednisone to prednisolone in man. Proc R Soc Med 1966; 59: 603-4."},{"key":"ref_142","first-page":"544","article-title":"Metabolic conversion of primidone","volume-title":"(Mysoline) to phenobarbital. Proc Soc Exp Biol Med 1956","volume":"93","author":"C, Butler T.; J, Waddell W.","unstructured":"Butler T C, Waddell W J. Metabolic conversion of primidone (Mysoline) to phenobarbital. Proc Soc Exp Biol Med 1956; 93: 544-6."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1476-5381.1971.tb07171.x","article-title":"Pharmacology of 4-hydroxypropranolol, a metabolite of propranolol","volume":"43","author":"D, Fitzgerald J.; R, O.'Donnell S.","year":"1971","unstructured":"Fitzgerald J D, O'Donnell S R. Pharmacology of 4-hydroxypropranolol, a metabolite of propranolol. Br J Pharmacol 1971; 43: 222-35.","journal-title":"Br J Pharmacol"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1542\/peds.53.6.873","article-title":"Indirect plasmatheophylline monitoring in asthmatic children by determination of theophylline concentration in saliva","volume":"53","author":"Levy, G.; F, Ellis E.; Koysooko, R.","year":"1974","unstructured":"Levy G, Ellis E F, Koysooko R. Indirect plasmatheophylline monitoring in asthmatic children by determination of theophylline concentration in saliva. Pediatrics 1974; 53: 873-6.","journal-title":"Pediatrics"}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/adc.55.2.89","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T03:44:15Z","timestamp":1684813455000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/adc.55.2.89"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1980,2,1]]},"references-count":144,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1980,2,1]]}},"URL":"https:\/\/doi.org\/10.1136\/adc.55.2.89","relation":{},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"value":"0003-9888","type":"print"},{"value":"1468-2044","type":"electronic"}],"subject":[],"published":{"date-parts":[[1980,2,1]]}}}